+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Amniotic Membrane Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • May 2021
  • Region: Global
  • TechNavio
  • ID: 4900059
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the amniotic membrane market and it is poised to grow by $954.86 million during 2021-2025, progressing at a CAGR of about 12% during the forecast period. The report on the amniotic membrane market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the extensive use of amniotic membrane transplantation in ophthalmic surgeries and the high demand for amniotic membrane in wound repair and reconstruction.

The amniotic membrane market analysis includes the type segment and geographic landscape.

The amniotic membrane market is segmented as below:

By Type
  • Cryopreserved amniotic membrane
  • Dehydrated amniotic membrane

By Geography
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rising demand for biocompatible scaffolds as one of the prime reasons driving the amniotic membrane market growth during the next few years.

The report on amniotic membrane market covers the following areas:
  • Amniotic membrane market sizing
  • Amniotic membrane market forecast
  • Amniotic membrane market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading amniotic membrane market vendors that include Celularity Inc., Stryker Corp., Surgenex LLC, Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc.TissueTech Inc., Integra LifeSciences Holdings Corp., and Human Regenerative Technologies LLC. Also, the amniotic membrane market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Cryopreserved amniotic membrane - Market size and forecast 2020-2025
  • Dehydrated amniotic membrane - Market size and forecast 2020-2025
  • Market opportunity by Type

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Celularity Inc.
  • Human Regenerative Technologies LLC
  • Integra LifeSciences Holdings Corp.
  • Katena Products Inc.
  • MiMedx Group Inc.
  • NuVision Biotherapies Ltd.
  • Orthofix Medical Inc.
  • Stryker Corp.
  • Surgenex LLC
  • TissueTech Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Type - Market share 2020-2025 (%)
  • Comparison by Type
  • Cryopreserved amniotic membrane - Market size and forecast 2020-2025 ($ million)
  • Cryopreserved amniotic membrane - Year-over-year growth 2020-2025 (%)
  • Dehydrated amniotic membrane - Market size and forecast 2020-2025 ($ million)
  • Dehydrated amniotic membrane - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Type
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Celularity Inc. - Overview
  • Celularity Inc. - Product and service
  • Celularity Inc. - Key offerings
  • Celularity Inc. - Key customers
  • Celularity Inc. - Segment focus
  • Human Regenerative Technologies LLC - Overview
  • Human Regenerative Technologies LLC - Product and service
  • Human Regenerative Technologies LLC - Key offerings
  • Human Regenerative Technologies LLC - Key customers
  • Human Regenerative Technologies LLC - Segment focus
  • Integra LifeSciences Holdings Corp. - Overview
  • Integra LifeSciences Holdings Corp. - Business segments
  • Integra LifeSciences Holdings Corp. - Key offerings
  • Integra LifeSciences Holdings Corp. - Key customers
  • Integra LifeSciences Holdings Corp. - Segment focus
  • Katena Products Inc. - Overview
  • Katena Products Inc. - Product and service
  • Katena Products Inc. - Key offerings
  • Katena Products Inc. - Key customers
  • Katena Products Inc. - Segment focus
  • MiMedx Group Inc. - Overview
  • MiMedx Group Inc. - Business segments
  • MiMedx Group Inc. - Key offerings
  • MiMedx Group Inc. - Key customers
  • MiMedx Group Inc. - Segment focus
  • NuVision Biotherapies Ltd. - Overview
  • NuVision Biotherapies Ltd. - Product and service
  • NuVision Biotherapies Ltd. - Key offerings
  • NuVision Biotherapies Ltd. - Key customers
  • NuVision Biotherapies Ltd. - Segment focus
  • Orthofix Medical Inc. - Overview
  • Orthofix Medical Inc. - Business segments
  • Orthofix Medical Inc. - Key offerings
  • Orthofix Medical Inc. - Key customers
  • Orthofix Medical Inc. - Segment focus
  • Stryker Corp. - Overview
  • Stryker Corp. - Business segments
  • Stryker Corp. - Key offerings
  • Stryker Corp. - Key customers
  • Stryker Corp. - Segment focus
  • Surgenex LLC - Overview
  • Surgenex LLC - Product and service
  • Surgenex LLC - Key offerings
  • Surgenex LLC - Key customers
  • Surgenex LLC - Segment focus
  • TissueTech Inc. - Overview
  • TissueTech Inc. - Product and service
  • TissueTech Inc. - Key offerings
  • TissueTech Inc. - Key customers
  • TissueTech Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global amniotic membrane market: Celularity Inc., Stryker Corp., Surgenex LLC, Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc.TissueTech Inc., Integra LifeSciences Holdings Corp., and Human Regenerative Technologies LLC.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the rising demand for biocompatible scaffolds.'

According to the report, one of the major drivers for this market is the extensive use of amniotic membrane transplantation in ophthalmic surgeries.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Celularity Inc.
  • Stryker Corp.
  • Surgenex LLC
  • Katena Products Inc.
  • MiMedx Group Inc.
  • NuVision Biotherapies Ltd.
  • Orthofix Medical Inc.TissueTech Inc.
  • Integra LifeSciences Holdings Corp.
  • Human Regenerative Technologies LLC